17356
3-(Boc-amino)propyl bromide
≥96.0% (GC)
Synonym(s):
tert-Butyl N-(3-bromopropyl)carbamate
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
Assay
≥96.0% (GC)
reaction suitability
reagent type: cross-linking reagent
mp
37-39 °C
functional group
Boc
amine
bromo
storage temp.
2-8°C
SMILES string
BrCCCNC(OC(C)(C)C)=O
InChI
1S/C8H16BrNO2/c1-8(2,3)12-7(11)10-6-4-5-9/h4-6H2,1-3H3,(H,10,11)
InChI key
IOKGWQZQCNXXLD-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Application
3-(Boc-amino)propyl bromide can be used as an alkylating reagent for the synthesis of:
It can also be used for the post-polymerization quaternization of polymers to synthesize functional cationic polymers and antimicrobial agents.
- Benzydamine analogs to be used as activators for soluble guanylate cyclase.
- N-substituted chromenotriazolopyrimidine, human murine double minute 2 (MDM2) inhibitor.
- Protected amines from piperidine derivatives to be further used for synthesis of sulfonamide series.
It can also be used for the post-polymerization quaternization of polymers to synthesize functional cationic polymers and antimicrobial agents.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Identification of selective 8-(piperidin-4-yloxy) quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis.
Bioorganic & Medicinal Chemistry Letters, 27(21), 4914-4919 (2017)
Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase.
Journal of medicinal chemistry, 44(1), 78-93 (2001)
Design, syntheses and evaluation of hemocompatible pegylated-antimicrobial polymers with well-controlled molecular structures.
Biomaterials, 31(7), 1751-1756 (2010)
Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors.
Bioorganic & Medicinal Chemistry Letters, 21(9), 2752-2755 (2011)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service